AKRIVIA is, at heart, an innovator focusing on precise cancer diagnostics and precision medicine. With intense research work done by our founder, who has deep expertise in the field of translational cancer science, we have developed first-of-its-kind innovative multi-tier method-based cancer classification systems that would significantly improve cancer diagnostics and lead to a ‘tailored precision medicine’ approach for the patients. At AKRIVIA, our vision is to help bring solutions to the market that drive cancer treatment strategies from the current one-size-fits-all approach to the precision medicine approach in its truest sense.